|
MechanismGABAB receptor antagonists [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc.United States |
First Approval Date01 Jan 1951 |
100 Clinical Results associated with Schwarz Pharma AG /Pharmaceuticals Manufacturing Operations/
0 Patents (Medical) associated with Schwarz Pharma AG /Pharmaceuticals Manufacturing Operations/
100 Deals associated with Schwarz Pharma AG /Pharmaceuticals Manufacturing Operations/
100 Translational Medicine associated with Schwarz Pharma AG /Pharmaceuticals Manufacturing Operations/